PMID- 35597955 OWN - NLM STAT- MEDLINE DCOM- 20220524 LR - 20230308 IS - 1755-8794 (Electronic) IS - 1755-8794 (Linking) VI - 15 IP - 1 DP - 2022 May 21 TI - Exome-wide analysis of copy number variation shows association of the human leukocyte antigen region with asthma in UK Biobank. PG - 119 LID - 10.1186/s12920-022-01268-y [doi] LID - 119 AB - BACKGROUND: The role of copy number variants (CNVs) in susceptibility to asthma is not well understood. This is, in part, due to the difficulty of accurately measuring CNVs in large enough sample sizes to detect associations. The recent availability of whole-exome sequencing (WES) in large biobank studies provides an unprecedented opportunity to study the role of CNVs in asthma. METHODS: We called common CNVs in 49,953 individuals in the first release of UK Biobank WES using ClinCNV software. CNVs were tested for association with asthma in a stage 1 analysis comprising 7098 asthma cases and 36,578 controls from the first release of sequencing data. Nominally-associated CNVs were then meta-analysed in stage 2 with an additional 17,280 asthma cases and 115,562 controls from the second release of UK Biobank exome sequencing, followed by validation and fine-mapping. RESULTS: Five of 189 CNVs were associated with asthma in stage 2, including a deletion overlapping the HLA-DQA1 and HLA-DQB1 genes, a duplication of CHROMR/PRKRA, deletions within MUC22 and TAP2, and a duplication in FBRSL1. The HLA-DQA1, HLA-DQB1, MUC22 and TAP2 genes all reside within the human leukocyte antigen (HLA) region on chromosome 6. In silico analyses demonstrated that the deletion overlapping HLA-DQA1 and HLA-DQB1 is likely to be an artefact arising from under-mapping of reads from non-reference HLA haplotypes, and that the CHROMR/PRKRA and FBRSL1 duplications represent presence/absence of pseudogenes within the HLA region. Bayesian fine-mapping of the HLA region suggested that there are two independent asthma association signals. The variants with the largest posterior inclusion probability in the two credible sets were an amino acid change in HLA-DQB1 (glutamine to histidine at residue 253) and a multi-allelic amino acid change in HLA-DRB1 (presence/absence of serine, glycine or leucine at residue 11). CONCLUSIONS: At least two independent loci characterised by amino acid changes in the HLA-DQA1, HLA-DQB1 and HLA-DRB1 genes are likely to account for association of SNPs and CNVs in this region with asthma. The high divergence of haplotypes in the HLA can give rise to spurious CNVs, providing an important, cautionary tale for future large-scale analyses of sequencing data. CI - (c) 2022. The Author(s). FAU - Fawcett, Katherine A AU - Fawcett KA AUID- ORCID: 0000-0002-6675-2112 AD - Department of Health Sciences, University of Leicester, Leicester, LE1 7RH, UK. kaf19@leicester.ac.uk. FAU - Demidov, German AU - Demidov G AD - Institute of Medical Genetics and Applied Genomics, University of Tubingen, Tubingen, Germany. FAU - Shrine, Nick AU - Shrine N AD - Department of Health Sciences, University of Leicester, Leicester, LE1 7RH, UK. FAU - Paynton, Megan L AU - Paynton ML AD - Department of Health Sciences, University of Leicester, Leicester, LE1 7RH, UK. FAU - Ossowski, Stephan AU - Ossowski S AD - Institute of Medical Genetics and Applied Genomics, University of Tubingen, Tubingen, Germany. FAU - Sayers, Ian AU - Sayers I AD - Translational Medical Sciences, NIHR Respiratory Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, University Park, Nottingham, UK. FAU - Wain, Louise V AU - Wain LV AD - Department of Health Sciences, University of Leicester, Leicester, LE1 7RH, UK. AD - Leicester Respiratory Biomedical Research Centre, National Institute for Health Research, Glenfield Hospital, Leicester, LE3 9QP, UK. FAU - Hollox, Edward J AU - Hollox EJ AD - Department of Genetics and Genome Biology, University of Leicester, Leicester, UK. LA - eng GR - MC_PC_17228/MRC_/Medical Research Council/United Kingdom GR - MC_QA137853/MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220521 PL - England TA - BMC Med Genomics JT - BMC medical genomics JID - 101319628 RN - 0 (Amino Acids) RN - 0 (HLA-DQ Antigens) RN - 0 (HLA-DRB1 Chains) RN - 0 (Histocompatibility Antigens Class I) SB - IM MH - Alleles MH - Amino Acids/genetics MH - *Asthma/genetics MH - Bayes Theorem MH - Biological Specimen Banks MH - *DNA Copy Number Variations MH - Exome MH - Genetic Predisposition to Disease MH - HLA-DQ Antigens/genetics MH - HLA-DRB1 Chains/genetics MH - Haplotypes MH - Histocompatibility Antigens Class I MH - Humans MH - United Kingdom MH - Exome Sequencing PMC - PMC9124406 OTO - NOTNLM OT - Asthma OT - Copy number variants OT - Exome sequencing OT - Fine-mapping OT - Genetic association OT - Human leukocyte antigen OT - UK Biobank COIS- LVW has research funding (outside of submitted work) from GSK and Orion Pharma and consultancy for Galapagos. All other authors declare that they have no competing interests. EDAT- 2022/05/22 06:00 MHDA- 2022/05/25 06:00 PMCR- 2022/05/21 CRDT- 2022/05/21 23:36 PHST- 2022/02/27 00:00 [received] PHST- 2022/05/10 00:00 [accepted] PHST- 2022/05/21 23:36 [entrez] PHST- 2022/05/22 06:00 [pubmed] PHST- 2022/05/25 06:00 [medline] PHST- 2022/05/21 00:00 [pmc-release] AID - 10.1186/s12920-022-01268-y [pii] AID - 1268 [pii] AID - 10.1186/s12920-022-01268-y [doi] PST - epublish SO - BMC Med Genomics. 2022 May 21;15(1):119. doi: 10.1186/s12920-022-01268-y.